OHSU
Categories | Inventors

Rabbit polyclonal antibody directed against human cytomegalovirus protein UL128

 

OHSU # 1260-C

Summary:

Technology Overview: Rabbit polyclonal antisera against human cytomegalovirus (CMV) protein UL128 has been developed. This antisera is useful for research involving CMV. Please refer to the following publication for more information on this antisera.

Publication: Ryckman B.J., Rainish B.L., Chase M.C., Borton J.A., Nelson, J.A., Jarvis M.A., Johnson D.C. Characterization of the Human Cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virology (2008) 82(1):60-70.

Licensing Opportunity: The polyclonal antisera is available for non-exclusive licensing.

Aliquot provided: 0.5mL aliquots are provided. A minimum of three (3) aliquots of any combination of polyclonal antisera classified under OHSU Technology #1260 is required for each license/MTA.

Inventors:

Related Technologies:

  • OHSU # 1260 — Rabbit polyclonal antibodies directed against HCMV proteins gH, gL, UL128, UL130 and UL131
  • OHSU # 1260-A — Rabbit polyclonal antibody directed against human cytomegalovirus protein gH
  • OHSU # 1260-B — Rabbit polyclonal antibody directed against human cytomegalovirus protein gL
  • OHSU # 1260-D — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL130
  • OHSU # 1260-E — Rabbit polyclonal antibody directed against human cytomegalovirus protein UL131

Categories:

For more information, contact:

Trina Voss
Technology Development Manager
503-494-9839

OptionPrice
(terms)  $1500.00
(terms)  $2500.00